
06/26/2025
https://www.facebook.com/share/p/1AsMz48Go2/?mibextid=wwXIfr
Using a newly discovered byproduct of dying cancer cells, UW–Madison researchers Quanyin Hu, University of Wisconsin-Madison School of Pharmacy professor, and his team are developing personalized vaccines that could help keep aggressive tumors from recurring.
Read more: https://news.wisc.edu/uw-researchers-develop-personalized-cancer-vaccines-that-slow-tumor-recurrence-in-mice/